Skip to main content

Agilent Signs Software Co-Marketing Agreement with ACD/Labs

NEW YORK (GenomeWeb News) – Agilent Technologies and Advanced Chemistry Development said today that they have agreed to co-market ACD/Labs’ AutoChrom method-development software with Agilent’s ChemStation instrument-control software for its HPLC, Rapid Resolution LC, and LC/MS systems.
 
AutoChrom can perform combinations of column, solvent, and buffer screening experiments, as well as automatic method optimization, the companies said. When experiments are complete, the data are automatically transferred from the ChemStation control software back to AutoChrom for processing and interpretation.
 
ACD/AutoChrom for ChemStation supports Agilent 1100, 1200, and 1200 SL Series liquid chromatographs; and model G1946 and G1956 mass spectrometers.
 
The companies said they expect support for Agilent 6100 Series mass spectrometers to be available in the fourth quarter of 2008.

The Scan

US Supports Patent Waivers

NPR reports that the Biden Administration has announced its support for waiving intellectual property protections for SARS-CoV-2 vaccines.

Vaccines Versus Variants

Two studies find the Pfizer-BioNTech SARS-CoV-2 vaccine to be effective against viral variants, and Moderna reports on booster shots to combat variants.

CRISPR for What Ails You

The Wall Street Journal writes that CRISPR-based therapies could someday be used to treat common conditions like heart attacks.

Nature Papers Review Integration of Single-Cell Assay Data, Present Approach to Detect Rare Variants

In Nature this week: review of ways to integrate data from single-cell assays, and more.